Mrs Maria Ann Duffy, CNM | |
599 W State St Ste 301, Doylestown, PA 18901-2567 | |
(215) 489-2066 | |
(215) 482-1166 |
Full Name | Mrs Maria Ann Duffy |
---|---|
Gender | Female |
Speciality | Advanced Practice Midwife |
Location | 599 W State St Ste 301, Doylestown, Pennsylvania |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1912117565 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
367A00000X | Advanced Practice Midwife | MWOO8542L (Pennsylvania) | Primary |
Entity Name | Abington Memorial Hospital |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1366835571 PECOS PAC ID: 3274437736 Enrollment ID: O20150624002498 |
News Archive
Immusoft Corporation, a Seattle-Wash.-based cell therapy company, announced today that the U.S. Food and Drug Administration (FDA) has granted it Rare Pediatric Disease Designation (RPDD) for Iduronicrin genleukocel-T, Immusoft's Sleeping Beauty transposon-engineered autologous plasmablasts for the expression and delivery of alpha-L-iduronidase (IDUA) to treat Mucopolysaccharidosis type I (MPS I).
Presenting many new facts and figures, a 2nd edition of the International Osteoporosis Foundation Compendium of Osteoporosis has been launched to mark World Osteoporosis Day.
Over three hundred community members, stakeholders, and public health workers joined Los Angeles County Supervisor Mark Ridley-Thomas for a People's Hearing on Slum Housing and the unveiling of a position paper documenting the health crisis related to slum housing in Los Angeles.
Virtual reality simulation tools are already revolutionizing the way dentists are taught at Case Western Reserve University - and if M. Cenk Cavusoglu has his way, simulation technology at Case will also train the world's brain and heart surgeons.
Salix Pharmaceuticals, Ltd. today announced that NASDAQ has halted trading of the Company's common stock this morning. The Gastrointestinal Drugs Advisory Committee of the FDA is meeting today to discuss the efficacy and safety of the New Drug Application (NDA) for XIFAXAN® (rifaximin) Tablets, 550 mg for the maintenance of remission of hepatic encephalopathy.
› Verified 1 days ago
Entity Name | Regional Womens Health Group Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1750880118 PECOS PAC ID: 2961316328 Enrollment ID: O20180611002120 |
News Archive
Immusoft Corporation, a Seattle-Wash.-based cell therapy company, announced today that the U.S. Food and Drug Administration (FDA) has granted it Rare Pediatric Disease Designation (RPDD) for Iduronicrin genleukocel-T, Immusoft's Sleeping Beauty transposon-engineered autologous plasmablasts for the expression and delivery of alpha-L-iduronidase (IDUA) to treat Mucopolysaccharidosis type I (MPS I).
Presenting many new facts and figures, a 2nd edition of the International Osteoporosis Foundation Compendium of Osteoporosis has been launched to mark World Osteoporosis Day.
Over three hundred community members, stakeholders, and public health workers joined Los Angeles County Supervisor Mark Ridley-Thomas for a People's Hearing on Slum Housing and the unveiling of a position paper documenting the health crisis related to slum housing in Los Angeles.
Virtual reality simulation tools are already revolutionizing the way dentists are taught at Case Western Reserve University - and if M. Cenk Cavusoglu has his way, simulation technology at Case will also train the world's brain and heart surgeons.
Salix Pharmaceuticals, Ltd. today announced that NASDAQ has halted trading of the Company's common stock this morning. The Gastrointestinal Drugs Advisory Committee of the FDA is meeting today to discuss the efficacy and safety of the New Drug Application (NDA) for XIFAXAN® (rifaximin) Tablets, 550 mg for the maintenance of remission of hepatic encephalopathy.
› Verified 1 days ago
Entity Name | Abington Memorial Hospital |
---|---|
Entity Type | Part B Supplier - Hospital Department(s) |
Entity Identifiers | NPI Number: 1548825243 PECOS PAC ID: 3274437736 Enrollment ID: O20190723002404 |
News Archive
Immusoft Corporation, a Seattle-Wash.-based cell therapy company, announced today that the U.S. Food and Drug Administration (FDA) has granted it Rare Pediatric Disease Designation (RPDD) for Iduronicrin genleukocel-T, Immusoft's Sleeping Beauty transposon-engineered autologous plasmablasts for the expression and delivery of alpha-L-iduronidase (IDUA) to treat Mucopolysaccharidosis type I (MPS I).
Presenting many new facts and figures, a 2nd edition of the International Osteoporosis Foundation Compendium of Osteoporosis has been launched to mark World Osteoporosis Day.
Over three hundred community members, stakeholders, and public health workers joined Los Angeles County Supervisor Mark Ridley-Thomas for a People's Hearing on Slum Housing and the unveiling of a position paper documenting the health crisis related to slum housing in Los Angeles.
Virtual reality simulation tools are already revolutionizing the way dentists are taught at Case Western Reserve University - and if M. Cenk Cavusoglu has his way, simulation technology at Case will also train the world's brain and heart surgeons.
Salix Pharmaceuticals, Ltd. today announced that NASDAQ has halted trading of the Company's common stock this morning. The Gastrointestinal Drugs Advisory Committee of the FDA is meeting today to discuss the efficacy and safety of the New Drug Application (NDA) for XIFAXAN® (rifaximin) Tablets, 550 mg for the maintenance of remission of hepatic encephalopathy.
› Verified 1 days ago
Mailing Address | Practice Location Address |
---|---|
Mrs Maria Ann Duffy, CNM Po Box 22581, New York, NY 10087-2581 Ph: (610) 482-4795 | Mrs Maria Ann Duffy, CNM 599 W State St Ste 301, Doylestown, PA 18901-2567 Ph: (215) 489-2066 |
News Archive
Immusoft Corporation, a Seattle-Wash.-based cell therapy company, announced today that the U.S. Food and Drug Administration (FDA) has granted it Rare Pediatric Disease Designation (RPDD) for Iduronicrin genleukocel-T, Immusoft's Sleeping Beauty transposon-engineered autologous plasmablasts for the expression and delivery of alpha-L-iduronidase (IDUA) to treat Mucopolysaccharidosis type I (MPS I).
Presenting many new facts and figures, a 2nd edition of the International Osteoporosis Foundation Compendium of Osteoporosis has been launched to mark World Osteoporosis Day.
Over three hundred community members, stakeholders, and public health workers joined Los Angeles County Supervisor Mark Ridley-Thomas for a People's Hearing on Slum Housing and the unveiling of a position paper documenting the health crisis related to slum housing in Los Angeles.
Virtual reality simulation tools are already revolutionizing the way dentists are taught at Case Western Reserve University - and if M. Cenk Cavusoglu has his way, simulation technology at Case will also train the world's brain and heart surgeons.
Salix Pharmaceuticals, Ltd. today announced that NASDAQ has halted trading of the Company's common stock this morning. The Gastrointestinal Drugs Advisory Committee of the FDA is meeting today to discuss the efficacy and safety of the New Drug Application (NDA) for XIFAXAN® (rifaximin) Tablets, 550 mg for the maintenance of remission of hepatic encephalopathy.
› Verified 1 days ago
Allison Burdulis, CNM Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 54 E Oakland Ave, Doylestown, PA 18901 Phone: 215-348-4002 | |
Joanne Carol Ruth, C.N.M. Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 599 W State St Ste 301, Doylestown, PA 18901 Phone: 215-489-2066 Fax: 215-482-1166 | |
Ann Lynn Jaspan, C.N.M. Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 58 E Oakland Ave, Doylestown, PA 18901 Phone: 215-340-9027 Fax: 215-340-2447 | |
Ms. Capri Marie Rothgaber, C.N.M., W.H.C.N.P Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 54 E Oakland Ave, Doylestown, PA 18901 Phone: 215-348-4002 |